IMPLEMENTATION OF THE CONCEPT OF STANDARD OPERATING PROCEDURES INTO PRIMARY CARE PRACTICE: UTOPIA OR URGENT NEED? ArticleЗырянов С.К., Фитилев С.Б., Возжаев А.В., Шкребнева И.И., Тяжельников А.А., Шиндряева Н.Н.Качественная клиническая практика. 2020. С. 75-84
MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE: CURRENT VIEW OF THE PROBLEM ArticleFitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Kliuev D.A., Stepanyan L.N.Качественная клиническая практика. 2019. С. 66-80
RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF GLURAZIM® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS ArticleFitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Kudlay D.A., Gapchenko E.V., Markova O.A., Borozinets A.Y., Kazarov A.A., Pantyushenko M.S.Онкогематология. Том 14. 2019. С. 73-83
ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY) ArticleTsukanova K.O., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Klyuev D.A.Research Results in Pharmacology. Том 4. 2018. С. 47-58
FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) ArticleFitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Tsukanova K.O.Rational Pharmacotherapy in Cardiology. Том 14. 2018. С. 244-251
РОЛЬ ФАРМАЦЕВТИЧЕСКОГО ЗВЕНА В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ РАННИХ ФАЗ ArticleВозжаев А.В., Фитилев С.Б., Шкребнева И.И., Якушев В.А.Организационные аспекты проведения клинических исследований. 2017. С. 20-22
NON-PHARMACOLOGICAL SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED AMBULATORY INSTITUTION ArticleFitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Tsukanova K.O., Dimitrova D.A.Качественная клиническая практика. 2017. С. 25-28
DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY ArticleZyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 9. 2017. С. 4-10
СПЕЦИФИЧЕСКИЕ АСПЕКТЫ ПЕРВИЧНОЙ МЕДИЦИНСКОЙ ДОКУМЕНТАЦИИ В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ ArticleВозжаев А.В., Фитилев С.Б., Шкребнева И.И., Якушев В.А.Организационные аспекты проведения клинических исследований. 2017. С. 87-90
COMPARATIVE PHARMACOKINETIC STUDY OF BIOEQUIVALENCE OF METOPROLOL SUCCINATE PROLONGED DRUG FORMS ArticleFitilev S.B., Yakushev V.A., Titarova Y.Y., Vozzhaev A.V., Shkrebniova I.I.Клиническая фармакология и терапия. Том 21. 2012. С. 82-84
ОЦЕНКА ГИПОЛИПИДЕМИЧЕСКОЙ ТЕРАПИИ КАК КОМПОНЕНТА ВТОРИЧНОЙ ПРОФИЛАКТИКИ У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА (ФАРМАКОЭПИДЕМИОЛОГИЧЕСКОЕ ИССЛЕДОВАНИЕ) ArticleФитилев С.Б., Возжаев А.В., Шкребнева И.И., Титарова Ю.Ю., Сычева Е.А., Журавлев Р.И.Клиническая фармакология и терапия. Том 18. 2009. С. 95-96
ASSESSING THE IMPLEMENTATION OF THE RECOMMENDATIONS ON SECONDARY CARDIOVASCULAR PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION (A PHARMACO-EPIDEMIOLOGIC STUDY) ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Vozzhaev A.V.Cardiovascular Therapy and Prevention. Том 8. 2009. С. 71-75
QUALITY OF AMBULATORY PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE AND ITS COMPLICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Tsiruleva Y.Y.Cardiovascular Therapy and Prevention. Том 7. 2008. С. 9-14
STABLE ANGINA PECTORIS: POPULATION TRENDS, DIAGNOSTICS, SECONDARY PREVENTION, AND ANTIANGINAL THERAPY ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Doronkina M.K.Cardiovascular Therapy and Prevention. Том 5. 2006. С. 49-54
SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MOSCOW POPULATION PATIENTS WITH MYOCARDIAL INFARCTION ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Gromakovsaya S.V.Cardiovascular Therapy and Prevention. Том 4. 2005. С. 53-60